- Home
- HOND vs DCTH Comparison
HOND vs DCTH Comparison
Compare HOND & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOND
- DCTH
- Stock Information
- Founded
- HOND 2024
- DCTH 1988
- Country
- HOND United States
- DCTH United States
- Employees
- HOND N/A
- DCTH N/A
- Industry
- HOND
- DCTH Medical/Dental Instruments
- Sector
- HOND
- DCTH Health Care
- Exchange
- HOND NYSE
- DCTH Nasdaq
- Market Cap
- HOND 287.5M
- DCTH 379.5M
- IPO Year
- HOND 2024
- DCTH N/A
- Fundamental
- Price
- HOND $10.01
- DCTH $11.58
- Analyst Decision
- HOND
- DCTH Strong Buy
- Analyst Count
- HOND 0
- DCTH 4
- Target Price
- HOND N/A
- DCTH $21.50
- AVG Volume (30 Days)
- HOND 1.2K
- DCTH 441.0K
- Earning Date
- HOND 01-01-0001
- DCTH 11-08-2024
- Dividend Yield
- HOND N/A
- DCTH N/A
- EPS Growth
- HOND N/A
- DCTH N/A
- EPS
- HOND N/A
- DCTH N/A
- Revenue
- HOND N/A
- DCTH $22,644,000.00
- Revenue This Year
- HOND N/A
- DCTH $1,605.13
- Revenue Next Year
- HOND N/A
- DCTH $111.67
- P/E Ratio
- HOND N/A
- DCTH N/A
- Revenue Growth
- HOND N/A
- DCTH 945.91
- 52 Week Low
- HOND $9.97
- DCTH $2.84
- 52 Week High
- HOND $11.57
- DCTH $12.88
- Technical
- Relative Strength Index (RSI)
- HOND N/A
- DCTH 58.29
- Support Level
- HOND N/A
- DCTH $11.42
- Resistance Level
- HOND N/A
- DCTH $12.79
- Average True Range (ATR)
- HOND 0.00
- DCTH 0.66
- MACD
- HOND 0.00
- DCTH 0.11
- Stochastic Oscillator
- HOND 0.00
- DCTH 65.03
About HOND HCM II ACQUISITION CORP
HCM II Acquisition Corp is a blank check company.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.